Novartis AG expected to post earnings of $2.37 a share - Earnings Preview

• Novartis AG NOVN is expected to show a rise in quarterly revenue when it reports results on July 17 for the period ending June 30 2025

• The Basel Basel-stadt-based company is expected to report a 13.3% increase in revenue to $14.181 billion from $12.51 billion a year ago, according to the mean estimate from 8 analysts, based on LSEG data. (Majority Sales represents Net Sales)

• ​LSEG's mean analyst estimate for Novartis AG is for earnings of $2.37 per share.

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 8 "strong buy" or "buy," 14 "hold" and 4 "sell" or "strong sell."

• The mean earnings estimate of analysts had risen by about 1.1% in the last three months. ​

• Wall Street's median 12-month price target for Novartis AG is CHF105.00, about 8.2% above its last closing price of CHF96.43

Previous quarterly performance (using preferred earnings measure in US dollars). ​

This summary was machine generated July 15 at 06:34 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)